Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Inks Specimen Collection Service Deal for ColonSentry

NEW YORK (GenomeWeb News) — GeneNews said today that it has signed up a lab services provider to expand its colon cancer risk test in Southwestern Ontario.

Gamma-Dynacare Medical Laboratories will provide blood specimen collection services for the ColonSentry test from three of its patient service centers in London, Ontario. The company estimated that the agreement has potentially made its test available to the nearly 500,000 people in this region of Ontario who are between 50 and 79 years old.

Gamma-Dynacare also offers the specimen collection services for the ColonSentry at ten locations in the Greater Toronto Area.

Financial terms of the agreement were not released.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.